Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-25-113874

Director bought 1,575 shares at an average $127.28 ($200,466)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coleman Mark Director 2025-09-08 Purchase +800 $127.20 $101,760 47,437 D
Coleman Mark Director 2025-09-08 Purchase +287 $127.30 $36,535 47,724 D
Coleman Mark Director 2025-09-08 Purchase +488 $127.40 $62,171 48,212 D
Open-market purchases · 1,575 sh · avg $127.28 · $200,466
Loading xslF345X05/ownership.xml…